ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 58 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $289,000 | +26.2% | 75,000 | 0.0% | 0.05% | +10.6% |
| Q3 2015 | $229,000 | -28.0% | 75,000 | 0.0% | 0.05% | -24.2% |
| Q2 2015 | $318,000 | +9.7% | 75,000 | 0.0% | 0.06% | +5.1% |
| Q1 2015 | $290,000 | -42.6% | 75,000 | 0.0% | 0.06% | -44.9% |
| Q4 2014 | $505,000 | +22.6% | 75,000 | 0.0% | 0.11% | +11.5% |
| Q3 2014 | $412,000 | -46.4% | 75,000 | 0.0% | 0.10% | -45.1% |
| Q2 2014 | $769,000 | -14.7% | 75,000 | 0.0% | 0.18% | -20.5% |
| Q1 2014 | $901,000 | +6.2% | 75,000 | 0.0% | 0.22% | +4.3% |
| Q4 2013 | $848,000 | +4.8% | 75,000 | 0.0% | 0.21% | -4.1% |
| Q3 2013 | $809,000 | +16.4% | 75,000 | 0.0% | 0.22% | +14.6% |
| Q2 2013 | $695,000 | – | 75,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |